Clinical Trial Update: A Study of LY3473329 in Participants With Impaired and Normal Renal Function [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating LY3473329 in participants with impaired and normal renal function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• LY3473329

Snippet

Sponsor: Eli Lilly and Company | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED